While Meta says the goal is political balance and nuanced conversations, is it chasing social ideology over fixing algorithmic bias?
Google, Anthropic, and Microsoft unleash tools that automate, integrate, and generate—yet steep prices and security concerns could limit how fast businesses dive in.
Snap study shows the power of positive ads: Consumers reported higher brand recall when seeing ads that sparked "joy."
Anxiety around inflation, a deteriorating labor market, and trade war consequences have deepened consumer uncertainty about the US economy, with wide-ranging implications for retail.
Temu pulls its Google Shopping ads: The escalating US-China trade war puts the company’s business model at risk and threatens ad giants like Meta and Google.
Lowe’s agreed to buy Artisan Design Group for $1.33 billion: The move should enhance the home improvement retailer’s market position when the housing sector rebounds.
Apple rebrands its ad business to ‘Apple Ads’: The shift is part of the company’s ongoing efforts to bolster its ad offerings amid past struggles.
This could help the bank strengthen its ties with SMB clients and boost customer acquisition.
The issuers are taking a wait-and-see approach to gauge how Trump’s tariffs will play out
Even so, issuers may be slow to lift preemptive APR increases as they brace for economic turbulence
The card network is positioning itself at the forefront of the crypto payments space, centered on stablecoins
Albertsons struggles to fend off competition from mass merchants and club retailers: The grocer is leaning on promotions, private labels, and its pharmacy business to attract value-focused shoppers.
Pfizer’s push into weight-loss drugs suffers another setback: Novo Nordisk and Eli Lilly are cornering the market as pharma companies struggle to develop an effective weight-loss drug pill.
Rapidly growing healthcare providers are reinvesting in online marketing: Incumbents must embrace social and search marketing to ward off competition from telehealth and D2C providers.
Brand-name drug prices could see the biggest jumps under newly promised tariffs: The Trump administration’s renewed push for pharma tariffs would mean higher drug manufacturing costs across the board, but especially for brand-name medicines.
While several industries roll back DEI initiatives under the Trump administration, some companies are emphasizing the value of data diversity. Revry, a global LGBTQ+ streaming network, wants to offer advertisers more ways to represent and resonate with diverse audiences.